Production of 100 MG of IGG2A anti ctla-4
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201700569P
- Awardee
-
Absolute Antibody LIMITED UEI M4ENRGUMMGJ5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,200
Award facts
- Contract value 100% obligated
- $9,200.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Absolute Antibody LIMITED for $9,200 on August 24, 2017, for production of 100 mg of IgG2a anti-CTLA-4. Work was performed in San Diego, California. The order carried a firm fixed price and was completed by August 23, 2018.
Quick answers
Who was awarded contract HHSN261201700569P?
HHSN261201700569P was awarded to Absolute Antibody LIMITED by National Cancer Institute (National Institutes of Health) on August 24, 2017.
How much is contract HHSN261201700569P worth?
The government has obligated $9,200 on HHSN261201700569P.
Was contract HHSN261201700569P competed?
The extent of competition for HHSN261201700569P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award